![]() |
Proton Pump Inhibitors and the Treatment of Osteoporosi...
February 1, 2012 - Clinical , Featured By: Neal Shah – Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces the ability of bone to provide adequate structural support. The main cause of this decreased BMD is inadequate calcium intake or absorption. The decreased BMD can cause diffuse lesions throughout the skeletal system and can… |
![]() |
Should Plan B Have an Age Restriction?...
February 1, 2012 - Professional Advice / Opinions By: Marie Huang – Back in December, the FDA was overruled by the presidential administration to make Plan B (levonorgestrel 1.5 mg) an over-the-counter (OTC) medication.1 We became interested in the matter, and asked our fellow students if Plan B should be available to people of all ages directly off of drugstore / supermarket shelves… |
![]() |
FDA Approves Edarbyclor®...
January 1, 2012 - Clinical , In the News / Politics By: Gokul Kalla, Pharm.D. Candidate c/o 2013 – Hypertension is a chronic disease that affects one out of every three Americans. Leaving the condition untreated could increase the risk of serious health consequences such as a stroke or a heart attack. On December 21, the FDA approved Takeda Pharmaceuticals’ Edarbyclor® (azilsartan medoxomil and chlorthalidone) for… |
![]() |
Clevidipine in the Management of Hypertensive Emergency...
January 1, 2012 - Clinical , Featured By: Neal Shah – Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than or equal to 140 mmHg and a diastolic blood pressure (DBP) greater than or equal to 90 mmHg. Patients with Stage 1 HTN have a SBP between 140 and 159 mmHg and DBP between 90… |
![]() |
Stool Transplants in C. difficile Infections...
December 1, 2011 - Clinical , Featured By Ebey P. Soman – Many living organisms occupy our intestines to aid us with metabolism, recycling of hormones, and, most importantly, protection against foreign pathogens. When this normal flora of bacteria is altered or eliminated via antibiotic use, there is an opportunity for Clostridium difficile to infect us. Stool transplant, or fecal bacteriotherapy, is… |
![]() |
Ivabradine: A Novel I(f) Blocker for Stable Angina...
December 1, 2011 - Clinical By: Neal Shah – Part I: Preface. Part II: Brief review of cardiac electrophysiology. Part III: Ivabradine as a novel If blocker for the use of stable angina. Part IV: On the horizon: trimetazidine. – PREFACE When viewed anatomically, the heart may seem like a simple organ. However, the electrophysiological aspects of the heart are… |
![]() |
Event Spotlight: “Who Wants to be a PharmD?”...
December 1, 2011 - Events By: Marie Huang – As the studio lights dimmed and the dynamic music played in the background, many students gathered in St. Albert Hall B75 in anticipation of who will be crowned the game’s next “PharmD.” A competitive air dangled, but the crowd chattered excitedly as a generous lunch was provided. Four seats lined the… |
![]() |
The Future of Pharmacist Practice...
November 1, 2011 - Featured , Professional Advice / Opinions By: Dr. Bernard Sorofman – Foreword: Dr. Bernard Sorofman is a pharmacy professor and Chair of Pharmacy Practice and Science, as well as the Executive Associate Dean at the College of Pharmacy for the University of Iowa. One of our student editors, Ebey P. Soman, had the privilege to attend and meet Dr. Sorofman at… |